These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2153931)

  • 1. Neurologic crises in hereditary tyrosinemia.
    Mitchell G; Larochelle J; Lambert M; Michaud J; Grenier A; Ogier H; Gauthier M; Lacroix J; Vanasse M; Larbrisseau A
    N Engl J Med; 1990 Feb; 322(7):432-7. PubMed ID: 2153931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosinemia: the Quebec experience.
    Paradis K
    Clin Invest Med; 1996 Oct; 19(5):311-6. PubMed ID: 8889268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical and metabolic aspects of liver transplantation for tyrosinemia].
    Bruneau N; St-Vil D; Luks FI; LaBerge JM; Bensoussan AL; Blanchard H
    Ann Chir; 1993; 47(9):803-9. PubMed ID: 8141543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
    Hostetter MK; Levy HL; Winter HS; Knight GJ; Haddow JE
    N Engl J Med; 1983 May; 308(21):1265-7. PubMed ID: 6188953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nephropathy of type I tyrosinemia after liver transplantation.
    Laine J; Salo MK; Krogerus L; Kärkkäinen J; Wahlroos O; Holmberg C
    Pediatr Res; 1995 May; 37(5):640-5. PubMed ID: 7603784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA
    Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of oncofetal markers CA 125, CA 19-9, and alpha-fetoprotein in children with hereditary tyrosinemia type I.
    Pitkänen S; Salo MK; Kuusela P; Holmberg C; Simell O; Heikinheimo M
    Pediatr Res; 1994 Feb; 35(2):205-8. PubMed ID: 7513078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute peripheral neuropathy due to hereditary coproporphyria.
    Barohn RJ; Sanchez JA; Anderson KE
    Muscle Nerve; 1994 Jul; 17(7):793-9. PubMed ID: 8008008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
    Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
    Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic regenerating nodules in hereditary tyrosinemia.
    Day DL; Letourneau JG; Allan BT; Sharp HL; Ascher N; Dehner LP; Thompson WM
    AJR Am J Roentgenol; 1987 Aug; 149(2):391-3. PubMed ID: 3300223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical excision of a hepatoma complicating chronic tyrosinemia (author's transl)].
    Costil J; Taïeb B; Buffe D; Garel L; Boccon-Gibod L; Gruner M; Brissaud HE
    Arch Fr Pediatr; 1980 Mar; 37(3):187-90. PubMed ID: 6258535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement.
    Shoemaker LR; Strife CF; Balistreri WF; Ryckman FC
    Pediatrics; 1992 Feb; 89(2):251-5. PubMed ID: 1734392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
    Sassa S; Fujita H; Kappas A
    Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].
    Barkaoui E; Debray D; Habès D; Ogier H; Bernard O
    Arch Pediatr; 1999 May; 6(5):540-4. PubMed ID: 10370811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum type III procollagen in children with type I hereditary tyrosinemia.
    Pitkänen S; Salo MK; Vettenranta K; Näntö-Salonen K; Heikinheimo M
    J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):38-41. PubMed ID: 10400101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients.
    Dubois J; Garel L; Patriquin H; Paradis K; Forget S; Filiatrault D; Grignon A; Russo P; St-Vil D
    Pediatr Radiol; 1996 Dec; 26(12):845-51. PubMed ID: 8929295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sepsis, as the presenting form of hereditary tyrosinemia type I].
    Iglesias Niubo J; Riudor Taravilla E; Goma Brufau AR; Civit Colas MA; Suñé Gracia JM; Bertrán Sanges JM; Gallart Catalá A
    An Esp Pediatr; 1988 Sep; 29(3):235-8. PubMed ID: 3057981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
    Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
    Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
    [No Abstract]   [Full Text] [Related]  

  • 19. Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes.
    Poudrier J; Lettre F; Scriver CR; Larochelle J; Tanguay RM
    Mol Genet Metab; 1998 Jun; 64(2):119-25. PubMed ID: 9705236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.
    Kvittingen EA; Rootwelt H; Brandtzaeg P; Bergan A; Berger R
    J Clin Invest; 1993 Apr; 91(4):1816-21. PubMed ID: 8473520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.